{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05962229",
            "orgStudyIdInfo": {
                "id": "22-36348"
            },
            "secondaryIdInfos": [
                {
                    "id": "1R01DA057282-01",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/1R01DA057282-01"
                }
            ],
            "organization": {
                "fullName": "University of California, San Francisco",
                "class": "OTHER"
            },
            "briefTitle": "Comparative Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine",
            "officialTitle": "Comparative Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine",
            "therapeuticArea": [
                "Other"
            ],
            "study": "comparative-pharmacokinetics-and-pharmacodynamics-of-synthetic-nicotine"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06-01",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-09",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-07-17",
            "studyFirstSubmitQcDate": "2023-07-17",
            "studyFirstPostDateStruct": {
                "date": "2023-07-27",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-29",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of California, San Francisco",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute on Drug Abuse (NIDA)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "In a crossover study, experienced electronic cigarette users will vape 3 different forms of nicotine: natural (derived from tobacco), synthetic, or a 50:50 mixture of both natural and synthetic. The investigators will compare nicotine metabolism, cardiovascular effects, patterns of self-administration, and participants' feelings of craving/withdrawal and enjoyment."
        },
        "conditionsModule": {
            "conditions": [
                "Nicotine Dependence",
                "Nicotine Vaping"
            ],
            "keywords": [
                "Nicotine Pharmacokinetics",
                "Nicotine Pharmacodynamics",
                "Vaping",
                "E-cigarettes"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "interventionModelDescription": "Within-subject, single-blinded crossover study. Participants will be randomized to the order of the 3 conditions using a Latin Square design.",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "PARTICIPANT"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 18,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "S-nicotine (tobacco) as the starting condition",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will spend 8 hours in the hospital research ward where they will vape e-liquid containing 100% (S)-nicotine.",
                    "interventionNames": [
                        "Drug: (S)-Nicotine",
                        "Drug: (R)- nicotine",
                        "Drug: Racemic nicotine"
                    ]
                },
                {
                    "label": "R-nicotine (synthetic) as the starting condition",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will spend 8 hours in the hospital research ward where they will vape e-liquid containing 100% (R)-nicotine.",
                    "interventionNames": [
                        "Drug: (S)-Nicotine",
                        "Drug: (R)- nicotine",
                        "Drug: Racemic nicotine"
                    ]
                },
                {
                    "label": "Racemic (50:50 S- and R- nicotine) as the starting condition",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will spend 8 hours in the hospital research ward where they will vape e-liquid containing 50% (S)-nicotine and 50% (R)-nicotine.",
                    "interventionNames": [
                        "Drug: (S)-Nicotine",
                        "Drug: (R)- nicotine",
                        "Drug: Racemic nicotine"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "(S)-Nicotine",
                    "description": "Participants will spend 8 hours in the hospital research ward and will vape e-liquid containing 100% (S)-nicotine. They will vape following a standardized session, followed by a 4 hour abstinence period. Participants will then vape as they wish (ad libitum) for 90 minutes.",
                    "armGroupLabels": [
                        "R-nicotine (synthetic) as the starting condition",
                        "Racemic (50:50 S- and R- nicotine) as the starting condition",
                        "S-nicotine (tobacco) as the starting condition"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "(R)- nicotine",
                    "description": "Participants will spend 8 hours in the hospital research ward and will vape e-liquid containing 100% (R)-nicotine. They will vape following a standardized session, followed by a 4 hour abstinence period. Participants will then vape as they wish (ad libitum) for 90 minutes.",
                    "armGroupLabels": [
                        "R-nicotine (synthetic) as the starting condition",
                        "Racemic (50:50 S- and R- nicotine) as the starting condition",
                        "S-nicotine (tobacco) as the starting condition"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Racemic nicotine",
                    "description": "Participants will spend 8 hours in the hospital research ward and will vape e-liquid containing 50% (R)-nicotine and 50% (S)-nicotine. They will vape following a standardized session, followed by a 4 hour abstinence period. Participants will then vape as they wish (ad libitum) for 90 minutes.",
                    "armGroupLabels": [
                        "R-nicotine (synthetic) as the starting condition",
                        "Racemic (50:50 S- and R- nicotine) as the starting condition",
                        "S-nicotine (tobacco) as the starting condition"
                    ],
                    "otherNames": [
                        "50:50 mixture of (S)- and (R)-nicotine"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Mean Nicotine Exposure Over Time",
                    "description": "Plasma nicotine area under the concentrated time curve (AUC) (ng/ml\\*h)",
                    "timeFrame": "Up to 7 hours"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Mean Amount of Nicotine Consumed Over Time",
                    "description": "Nicotine self-administration determined by device weight change before and after use multiplied by the nicotine concentration in the e-liquid",
                    "timeFrame": "120 minutes"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Healthy on the basis of medical history and limited physical examination.\n* Current regular user of E-Cigarettes (\u2265 15 days in the past 30 days)\n\nExclusion Criteria:\n\n* \u2022 Medications\n\n  * Use of medications that are inducers of nicotine metabolizing enzyme CYP2A6 (Example: rifampicin, carbamazepine, phenobarbital, and other anticonvulsant drugs).\n  * Use of sympatholytic medications for cardiovascular conditions including hypertension (Example: beta and alpha-blockers).\n  * Concurrent use of nicotine-containing medications (Example: nicotine patch, lozenge, gum).\n  * Any stimulant medications (example: Adderall) generally given for ADHD treatment.\n\n    \u2022 Pregnancy\n  * Pregnancy (self-reported and urine pregnancy test)\n  * Breastfeeding (determined by self-report)\n  * Women of childbearing potential must be using an acceptable method of contraception\n\n    * Inability to read and write in English\n    * A known propylene glycol/vegetable glycerin allergy\n    * Uncomfortable with getting blood drawn",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "21 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Lisa Lawrence",
                    "role": "CONTACT",
                    "phone": "628-206-4204",
                    "email": "lisa.lawrence@ucsf.edu"
                },
                {
                    "name": "Armando Barraza",
                    "role": "CONTACT",
                    "phone": "510-560-4842",
                    "email": "armando.barraza@ucsf.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Neal Benowitz, MD",
                    "affiliation": "University of California, San Francisco",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Zuckerberg San Francisco General Hospital (ZSFG)",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94110",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lisa Lawrence",
                            "role": "CONTACT",
                            "phone": "628-206-4204",
                            "email": "lisa.lawrence@ucsf.edu"
                        },
                        {
                            "name": "Armando Barraza",
                            "role": "CONTACT",
                            "phone": "510-560-4842",
                            "email": "armando.barraza@ucsf.edu"
                        },
                        {
                            "name": "Neal Benowitz, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014029",
                    "term": "Tobacco Use Disorder"
                }
            ],
            "ancestors": [
                {
                    "id": "D000019966",
                    "term": "Substance-Related Disorders"
                },
                {
                    "id": "D000064419",
                    "term": "Chemically-Induced Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16785",
                    "name": "Tobacco Use Disorder",
                    "asFound": "Nicotine Dependence",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21837",
                    "name": "Substance-Related Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M30302",
                    "name": "Chemically-Induced Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009538",
                    "term": "Nicotine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005731",
                    "term": "Ganglionic Stimulants"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018722",
                    "term": "Nicotinic Agonists"
                },
                {
                    "id": "D000018679",
                    "term": "Cholinergic Agonists"
                },
                {
                    "id": "D000018678",
                    "term": "Cholinergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12478",
                    "name": "Nicotine",
                    "asFound": "Assess",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4029",
                    "name": "Central Nervous System Stimulants",
                    "relevance": "LOW"
                },
                {
                    "id": "M20796",
                    "name": "Nicotinic Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20758",
                    "name": "Cholinergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "CNSSti",
                    "name": "Central Nervous System Stimulants"
                }
            ]
        }
    },
    "hasResults": false
}